The familial risk of subarachnoid haemorrhage

被引:48
|
作者
Teasdale, GM
Wardlaw, JM
White, PM
Murray, G
Teasdale, EM
Easton, V
机构
[1] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland
[2] So Gen Hosp, Univ Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland
[3] So Gen Hosp, Inst Neurol Sci, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland
[4] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland
关键词
subarachnoid haemorrhage; intracranial aneurysm; familial risk; epidemiology; screening;
D O I
10.1093/brain/awh497
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Relatives of people with aneurysmal subarachnoid haemorrhage (SAH) may be at increased risk of SAH, but precise data on the level of risk and which relatives are most likely to be affected are lacking. We studied two samples: 5478 relatives of patients from the whole of Scotland who had a SAH in one year and 3213 relatives of patients with a SAH admitted to the West of Scotland regional neurosurgical unit 10 years previously. Overall, 2% of all relatives in each sample had a SAH. In the Scotland-wide sample, the absolute lifetime risk of SAH (from birth to 70 years) was higher for first-degree relatives [4.7%; 95% confidence interval (CI): 3.1-6.3%] than for second-degree (1.9%; 95% CI: 1.0-2.9%). In the West of Scotland sample, the lifetime risks were very similar to the Scotland-wide sample. The 10-year prospective risk for first-degree relatives alive at the time of the index patient's SAH was 1.2% (95% CI: 0.4-2%) and for second-degree was 0.5% (95% CI: 0.1-0.8%). There was a trend for risk to be highest in families with two first-degree relatives affected and lowest with only one second-degree affected. Most living relatives of patients who suffer a SAH are at low absolute risk of a future haemorrhage; screening is inappropriate except for the few families in whom two or more first-degree relatives, i.e. index case plus one extra have been affected.
引用
收藏
页码:1677 / 1685
页数:9
相关论文
共 50 条
  • [1] Corticosteroid use and risk of aneurysmal subarachnoid haemorrhage
    Y. M. Ruigrok
    P. J. W. Dekkers
    J. E. C. Bromberg
    A. Algra
    G. J. E. Rinkel
    Journal of Neurology, 2006, 253
  • [2] Corticosteroid use and risk of aneurysmal subarachnoid haemorrhage
    Ruigrok, YM
    Dekkers, PJW
    Bromberg, JEC
    Algra, A
    Rinkel, GJE
    JOURNAL OF NEUROLOGY, 2006, 253 (04) : 496 - 499
  • [4] Management of subarachnoid haemorrhage
    Odili, Anwuli
    Reddy, Ugan
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2023, 24 (06) : 340 - 347
  • [5] Update on subarachnoid haemorrhage
    Ferro, Jose M.
    Canhao, P.
    Peralta, R.
    JOURNAL OF NEUROLOGY, 2008, 255 (04) : 465 - 479
  • [6] Update on subarachnoid haemorrhage
    J. M. Ferro
    P. Canhão
    R. Peralta
    Journal of Neurology, 2008, 255 : 465 - 479
  • [7] Blood cadmium concentration and risk of subarachnoid haemorrhage
    Soderholm, Martin
    Borne, Yan
    Hedblad, Bo
    Persson, Margaretha
    Barregard, Lars
    Engstrom, Gunnar
    ENVIRONMENTAL RESEARCH, 2020, 180
  • [8] Spontaneous subarachnoid haemorrhage:: A study of 462 patients
    Parkhutik, V.
    Lago, A.
    Tembl, J. I.
    Beltran, A.
    Fuset, M. P.
    REVISTA DE NEUROLOGIA, 2008, 46 (12) : 705 - 708
  • [9] Incidence and case fatality of subarachnoid haemorrhage in Northern Greece: the Evros Registry of Subarachnoid Haemorrhage
    Vadikolias, K.
    Tsivgoulis, G.
    Heliopoulos, I.
    Papaioakim, M.
    Aggelopoulou, C.
    Serdari, A.
    Birbilis, T.
    Piperidou, C.
    INTERNATIONAL JOURNAL OF STROKE, 2009, 4 (05) : 322 - 327
  • [10] Management of aneurysmal subarachnoid haemorrhage
    Schatlo, Bawarjan
    Fathi, Ali-Reza
    Fandino, Javier
    SWISS MEDICAL WEEKLY, 2014, 144